/Companies

Pierrepont Therapeutics

Brooklyn, US · Founded 2020 · Delaware corporation

Find your way into Pierrepont Therapeutics

Sign up to see every warm intro you have to Pierrepont Therapeutics

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Pierrepont Therapeutics team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Founders & leadership

MW
Matthew WyckoffNamed on SEC filing
PH
Peter H. BarberNamed on SEC filing
DD
Daniel DiPietroNamed on SEC filing

Reported raises · per SEC filings

Form D private placements

$2.4M disclosed across 1 round · 2024

▶$2.4MraisedSep 2026 · 2 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Peter H. BarberExecutive Officer, Director
  • Daniel DiPietroDirector
  • Matthew WyckoffDirector
Offering amount
$5.9M
Amount sold
$2.4M
First sale
Apr 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

How much funding has Pierrepont Therapeutics raised?
Pierrepont Therapeutics has disclosed $2.4M raised across 1 round.
Where is Pierrepont Therapeutics headquartered?
Pierrepont Therapeutics is headquartered in Brooklyn, US.